Charles Schwab Investment Management Inc. Increases Stock Holdings in Encompass Health Corporation $EHC

Key Points

• Charles Schwab Investment Management Inc. increased its stake in Encompass Health Corporation by 6.3%, owning approximately 685,577 shares worth $69.4 million at the end of the reporting period.
• Encompass Health recently posted a quarterly earnings report showing an EPS of $1.40, exceeding estimates, with revenue of $1.46 billion, a 12% increase year-over-year.
• The company announced a quarterly dividend of $0.19 per share, reflecting a positive increase from the previous $0.17, with a dividend yield of 0.6% and a payout ratio of 13.31%.

Charles Schwab Investment Management Inc. lifted its position in Encompass Health Corporation (NYSE:EHC - Free Report) by 6.3% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 685,577 shares of the company's stock after purchasing an additional 40,813 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately 0.68% of Encompass Health worth $69,435,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in the company. OneDigital Investment Advisors LLC acquired a new position in Encompass Health in the 1st quarter valued at about $263,000. GAMMA Investing LLC increased its holdings in shares of Encompass Health by 21.5% in the first quarter. GAMMA Investing LLC now owns 2,366 shares of the company's stock valued at $240,000 after purchasing an additional 419 shares during the period. Sequoia Financial Advisors LLC raised its stake in shares of Encompass Health by 6.7% during the first quarter. Sequoia Financial Advisors LLC now owns 2,727 shares of the company's stock worth $276,000 after purchasing an additional 172 shares during the last quarter. Cambridge Investment Research Advisors Inc. lifted its holdings in shares of Encompass Health by 30.1% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 9,597 shares of the company's stock worth $972,000 after purchasing an additional 2,218 shares during the period. Finally, Fifth Third Bancorp grew its position in Encompass Health by 88.7% in the 1st quarter. Fifth Third Bancorp now owns 4,290 shares of the company's stock valued at $434,000 after buying an additional 2,017 shares during the last quarter. Institutional investors and hedge funds own 97.25% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have recently commented on EHC shares. Royal Bank Of Canada raised their target price on shares of Encompass Health from $110.00 to $125.00 and gave the stock an "outperform" rating in a research note on Monday, April 28th. Wall Street Zen cut Encompass Health from a "strong-buy" rating to a "buy" rating in a research report on Friday, June 6th. UBS Group raised their price target on Encompass Health from $130.00 to $140.00 and gave the company a "buy" rating in a report on Wednesday, August 6th. Stephens raised Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price objective on the stock in a report on Thursday, June 5th. Finally, Truist Financial set a $140.00 target price on shares of Encompass Health and gave the stock a "buy" rating in a research report on Thursday, August 14th. Seven equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Buy" and an average target price of $134.00.

Encompass Health Price Performance

Shares of Encompass Health stock traded up $1.82 during trading on Tuesday, hitting $122.04. 86,987 shares of the company were exchanged, compared to its average volume of 815,316. Encompass Health Corporation has a fifty-two week low of $87.85 and a fifty-two week high of $123.13. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.76. The firm has a 50 day moving average price of $116.13 and a 200 day moving average price of $109.78. The stock has a market capitalization of $12.29 billion, a price-to-earnings ratio of 23.89, a P/E/G ratio of 2.10 and a beta of 0.86.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The company reported $1.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.20 by $0.20. The business had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%. The business's revenue was up 12.0% on a year-over-year basis. During the same period in the prior year, the business earned $1.11 earnings per share. On average, equities analysts expect that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be paid a dividend of $0.19 per share. The ex-dividend date of this dividend is Wednesday, October 1st. This is a positive change from Encompass Health's previous quarterly dividend of $0.17. This represents a $0.76 annualized dividend and a dividend yield of 0.6%. Encompass Health's payout ratio is currently 13.31%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.